Congressional Stock Trades & Disclosures
Thom Tillis is a U.S. Senator, a Republican representing NC. As of July 2023, Quantellect has tracked 114 disclosed stock trades across 97 companies, representing $961.06K in disclosed transaction value, each filed publicly under the STOCK Act.
About Thom Tillis's congressional trading
Every transaction in Senator Thom Tillis's disclosure record is a sale. Across 114 recorded transactions in Quantellect's database, there is no purchase and no transaction classified as "other", only sales, some marked "Sale (Full)" and some "Sale (Partial)." That gives the record a distinctive all-sale profile. And the record is heavily front-loaded: 107 of those 114 transactions occurred in 2015, beginning on February 5, with a large cluster dated February 13.
That concentration matters for how to read the rest of the record. This is not a disclosure record showing a steady stream of sales over a decade. It is dominated by a broad wave of sales in early 2015, followed by a handful of scattered sales in the years since. The database's yearly breakdown shows recorded activity in only four years: 107 transactions in 2015, three in 2017, three in 2018, and one in 2022. No purchases appear in any of those years.
A Large 2015 Sell-Off, Then Occasional Follow-On Sales
The 2015 activity is broad rather than concentrated in a few names. Across the full record, no ticker among the "most frequently disclosed securities" appears more than twice, and sixteen different tickers are tied at two disclosures apiece: AFSI, AMSG, AQFH, CTCT, CVS, EPAY, FET, IPCM, NICE, NSR, POWI, PRA, PRLB, QLIK, SWI, and TECH. The 2015 activity also includes dozens of single-transaction sales spread across a wide range of names, from Casey's General Stores and Steven Madden to Bio-Rad Laboratories, Evercore, Toro, and Texas Capital Bancshares. The pattern is broad, with many individual equities sold during the same short window rather than a small set of repeat transactions.
Most of the February 13, 2015 sales shown in the transaction detail carry a disclosure date of February 26, 2015. But a subset of those sales, including SWI, QLIK, IPCM, AMSG, PRA, PRLB, FET, NSR, CTCT, EPAY, POWI, TECH, and AFSI, carries a disclosure date of August 28, 2023, more than eight years after the transaction itself. The database attributes the entire 2015 activity, including both the earlier- and later-disclosed portions, to "Unknown or not available from source," meaning the available source data does not identify whether these were the senator's own trades, a spouse's, a dependent's, or another covered account. That attribution gap applies to 107 of the 114 total transactions in the record.
The remaining seven transactions are attributed more specifically: six are marked "Joint," and one is marked "Self." The Joint transactions cluster in two windows. In early 2017, three joint sales of Aquesta Financial Holdings shares were disclosed on February 17, 2017, within about three weeks of the underlying trades. In December 2018, three transactions tied to a joint account were disclosed across three separate filings between February and July 2019: two partial or full sales of CVS Health Corporation stock, and a full sale of a Munder Funds multi-cap mutual fund product. The lone "Self" transaction is the most recent entry in the record: a full sale of Kyndryl Holdings, Inc. common stock, transacted August 30, 2022, and disclosed nearly eleven months later on July 15, 2023.
Sector Mix and Notable Names
Where a sector is identified, the sale activity skews toward Industrials (13 transactions), Health Care (12), Information Technology (11), and Financials (9), with smaller counts in Consumer Discretionary (4), Consumer Staples (4), Energy (4), Materials (3), Real Estate (2), and Utilities (1). A large share of the record, 51 of 114 transactions, has no sector classification in the underlying data; many of those rows also lack an attribution and a company name.
Among the transactions the database can identify by company, several are large, well-known operating businesses. CVS Health Corporation, sold twice in the 2018 joint-account transactions, is a national health care benefits, pharmacy services, and retail pharmacy company. Kyndryl Holdings, Inc., the subject of the 2022 self-attributed sale, is an IT infrastructure services provider incorporated in 2020, serving financial, health care, public-sector, and telecom clients globally. ProAssurance Corporation, sold in the 2015 activity, underwrites professional liability insurance for health care providers. Forum Energy Technologies, also part of that activity, supplies equipment and other products serving the oil, natural gas, defense, and renewable-energy industries. Power Integrations designs semiconductors used in power conversion for consumer electronics, industrial equipment, and electric vehicles. Proto Labs operates a digital manufacturing platform for custom machined and 3D-printed parts. Bio-Techne Corporation makes reagents and instruments for life-science research and diagnostics.
Taken together, these named sales span several of the sectors most visible in the disclosure record and illustrate how broadly the 2015 activity was distributed across companies.
Disclosure Timing and Context
Members of Congress are required to report covered securities transactions under the Stop Trading on Congressional Knowledge Act of 2012, and the Senate's disclosure process is documented by the Senate Select Committee on Ethics. Within Tillis's record, disclosure lags vary widely: the 2017 Aquesta Financial Holdings sales were reported within about three weeks, while the 2022 Kyndryl sale took nearly eleven months to appear, and a portion of the 2015 activity carries a 2023 disclosure date.
Across the full population tracked in this database, 537 members of Congress are currently sitting, and 276 of them, including 39 of the 100 sitting senators, have no disclosed trades at all. Tillis's 114 transactions place him outside that non-trading group. A trading score is not currently published for Tillis: no score row exists for this subject as of the latest published scoring date, a status shared by the majority of sitting members, since scores are currently available for only 73 of the 537.
About This Data and Its Limits
- Figures on this page reflect transactions disclosed in official congressional financial filings and are limited to what has been captured in our database as of the dates shown.
- Transaction date reflects when the trade reportedly occurred; disclosure date reflects when it was filed. These can differ by weeks, months, or, in a portion of this record, years.
- Where attribution is marked "Unknown," the available source data does not specify whether the transaction belongs to the member personally, a spouse, a dependent child, or another covered account. Where marked "Joint," it reflects joint attribution rather than a solely self-attributed transaction.
- Dollar figures in this dataset are disclosed as ranges, not exact amounts.
- This page does not provide investment advice and should not be relied upon as the sole basis for any investment decision.
Trading activity
Where the Money Sits
share of disclosed trades · top sectors
Periodic Transaction Report filings
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
KDKyndryl Holdings Inc | Sell | $1,001 - $15,000 | 30 AUG 2022 | $10.62 | +22.60% |
CVSCVS Health Corp | Sell | $1,001 - $15,000 | 20 DEC 2018 | $52.09 | +78.33% |
CVSCVS Health Corp | Sell | $1,001 - $15,000 | 20 DEC 2018 | $52.09 | +78.33% |
Victory Portfolio Munder Multi-Cap Mutual Fund Company: Munder Funds (Coloumbus, OH) | Sell | $1,001 - $15,000 | 20 DEC 2018 | — | — |
| Sell | $1,001 - $15,000 | 03 FEB 2017 | — | — | |
| Sell | $15,001 - $50,000 | 01 FEB 2017 | — | — | |
AQFH-Aquesta Financial Holdings, Inc. | Sell | $15,001 - $50,000 | 26 JAN 2017 | — | — |
| Sell | $1,001 - $15,000 | 13 FEB 2015 | — | — | |
TECHBio-Techne Corp | Sell | $1,001 - $15,000 | 13 FEB 2015 | $21.80 | +231.82% |
POWIPower Integrations Inc | Sell | $1,001 - $15,000 | 13 FEB 2015 | $24.41 | +123.83% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Thom Tillis congressional trading FAQ
Can Thom Tillis legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Thom Tillis's disclosures so the public can review them.
Where does Quantellect get Thom Tillis's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Thom Tillis's stock trades?
Quantellect tracks every stock trade Thom Tillis discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Thom Tillis disclosed?
Quantellect has tracked 114 disclosed trades by Thom Tillis across 97 companies.
Which stocks does Thom Tillis trade most?
Thom Tillis's most frequently disclosed positions are AFSI (2 disclosed trades), AMSG (2 disclosed trades), AQFH (2 disclosed trades), CTCT (2 disclosed trades), CVS (2 disclosed trades), and EPAY (2 disclosed trades), followed by FET, IPCM, NICE, and NSR. The full list of companies and individual filings is shown on this page.
Which sectors does Thom Tillis invest in?
Healthcare is the heaviest sector in Thom Tillis's classified disclosures, covering 13 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.
What was Thom Tillis's most recent stock trade?
Thom Tillis most recently sold Kyndryl Holdings Inc (KD) in August 2022, according to public STOCK Act filings tracked by Quantellect.
What is Thom Tillis's Quantellect Score?
Thom Tillis has a directory baseline value of 10, not a measured Quantellect Score. No disclosed purchases were found in the trailing 24-month scoring window; at least 2 eligible priced purchases are required for a measured Q Score. Baseline 10 is a directory value, not a measured Q Score, and is excluded from ranking and percentile calculations.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.





